Iruma, Japan

Tomohiro Emura



Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 78(Granted Patents)


Location History:

  • Iruma, JP (1998 - 2001)
  • Hanno, JP (2010 - 2017)

Company Filing History:


Years Active: 1998-2017

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Tomohiro Emura: Innovator in Cancer Treatment

Introduction

Tomohiro Emura is a notable inventor based in Iruma, Japan. He has made significant contributions to the field of cancer treatment through his innovative methods and formulations. With a total of 6 patents to his name, Emura continues to push the boundaries of medical science.

Latest Patents

Emura's latest patents focus on methods of administering anticancer drugs. One of his notable inventions is a method for treating cancer that involves orally administering a composition containing α,α,α-trifluorothymidine (FTD) and a thymidine phosphorylase inhibitor. This method specifies a molar ratio of 1:0.5 and a dosage of 20 to 80 mg/m/day in terms of FTD, divided into 2 to 4 portions for patients in need of treatment.

Career Highlights

Emura is currently associated with Taiho Pharmaceutical Company Limited, where he applies his expertise in pharmaceutical innovation. His work has been instrumental in developing effective cancer therapies that improve patient outcomes.

Collaborations

Emura collaborates with esteemed colleagues such as Shingo Yano and Yukio Tada. Their combined efforts contribute to advancing research and development in the pharmaceutical industry.

Conclusion

Tomohiro Emura's innovative approaches to cancer treatment exemplify the impact of dedicated inventors in the medical field. His contributions continue to pave the way for advancements in therapeutic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…